Grand Vapors
Letter data
- Company
- Grand Vapors
- Recipient
- Karisa Jones | Grand Vapors | United States | info@grandvapors.com | karisajones1414@gmail.com
- Issue date
- 2021-07-30
- Posted date
- Not available
- FDA office
- Center for Tobacco Products
- Subject
- Not available
- Product
- Tobacco
- CMS ID
- 613962
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Grand Vapors
MARCS-CMS 613962 —
July 30, 2021
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Tobacco
Recipient:
Recipient Name
Karisa Jones
Grand Vapors
United States
info@grandvapors.com
karisajones1414@gmail.com
Issuing Office:
Center for Tobacco Products
United States
Dear Karisa Jones,
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions following the issuance of our Warning Letter dated March 26, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.grandvapors.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
Mallory Bowling
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
cc:
GoDaddy.com LLC
abuse@godaddy.com
Cloudflare, Inc.
abuse@cloudflare.com
Content current as of:
08/16/2023
Regulated Product(s)
Tobacco